Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Agiliti reports earnings beat, revenue growth in fourth quarter

EditorNatashya Angelica
Published 03/05/2024, 04:14 PM
Updated 03/05/2024, 04:14 PM
© Reuters.

EDEN PRAIRIE, Minn. - Agiliti Inc. (NYSE: AGTI), a leading nationwide provider of healthcare technology management and service solutions, announced a modest beat on adjusted earnings per share (EPS) for the fourth quarter, while also reporting a revenue increase compared to the same quarter last year.

The company reported an adjusted EPS of $0.13, which was $0.01 higher than the analyst consensus of $0.12. Fourth quarter revenue reached $292 million, slightly above the analyst expectations of $291.41 million, marking a 4% growth from the $281.7 million reported in the fourth quarter of the previous year.

Despite the revenue growth, the company experienced a net loss of $5.7 million in the fourth quarter, a decline from the net income of $3.4 million reported in the same period last year. The diluted loss per share was $0.04, in contrast to the diluted earnings per share of $0.02 from the prior year.

Adjusted EBITDA for the quarter was $67.3 million, which represents a decrease of 5.7% from the $71.4 million in the fourth quarter of 2022.

For the full year of 2023, Agiliti saw a revenue increase of 5% to $1.17 billion, up from $1.12 billion in the previous year. Still, the company recorded a net loss of $19.4 million for the year, compared to a net income of $30.2 million in the prior year. The full-year adjusted EPS was $0.55, down from $0.85 in the previous year.

The company has also announced a significant change in its ownership structure. On Monday, February 26, 2024, Agiliti disclosed that it has entered into a definitive merger agreement in which an affiliate of private equity firm Thomas H. Lee Partners, L.P. (THL), the company’s majority shareholder, will take the company private.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The transaction, valued at approximately $2.5 billion, is expected to close in the first half of 2024, after which Agiliti will no longer be publicly traded on the New York Stock Exchange.

Agiliti's CEO commented on the results, noting that the company's focus on providing essential services to the healthcare industry has driven the revenue growth, despite the challenges faced in the fourth quarter. The CEO also expressed confidence in the company's strategic direction and the value it will continue to deliver as a private entity post-acquisition.

While the company did not provide guidance for upcoming quarters due to the pending acquisition, the overall financial performance and the announcement of going private reflect a period of transition for Agiliti. The company's long-standing commitment to supporting efficient, safe, and sustainable healthcare delivery systems remains at the core of its operations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.